← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Arbor Vita Corporation
Fremont, CA
$7,957,802
Total funding
12
Grants
Funding over time
peak $2.4M · FY2005–13$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$7,957,802 · 12
By mechanism
R44$5,380,495 · 4
R43$2,577,307 · 8
Investigators at Arbor Vita Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of an E6 based Rapid Strip Test Commercial Prototype for Cervical Can$1,000,000
R44 · FY2010 · AI
Development of an E6 based Rapid Strip Test Commercial Prototype for Cervical Can$1,000,000
R44 · FY2009 · AI
Commercialization of the OncoE6TM Cervical Test for detection of HPV induced mali$961,000
R44 · FY2013 · CA
Translation of a Novel Stroke Drug Administration$859,405
R44 · FY2010 · NS
Translation of a Novel Stroke Drug Administration$684,392
R44 · FY2009 · NS
A Novel Diagnostic Assay for Oncogenic Human Papillomaviruses$478,244
R44 · FY2006 · CA
A Novel Diagnostic Assay for Oncogenic Human Papillomaviruses$397,454
R44 · FY2007 · CA
E6 Oncoprotein Based Rapid Test for Anal Neoplasia$353,742
R43 · FY2010 · CA
E6 Oncoprotein Based Rapid Test for Anal Neoplasia$338,612
R43 · FY2011 · CA
Rapid Strip Test for Cervical Cancer via HPV-E6 Detection$299,016
R43 · FY2007 · AI
Rapid Strip Test for Cervical Cancer via HPV-E6 Detection$298,481
R43 · FY2006 · AI
PDZ-targeted Therapeutics for Cervical Cancer$208,622
R43 · FY2010 · CA
Prevention and Treatment of Cervical Cancer$200,186
R43 · FY2003 · CA
A NOVEL FAMILY OF LYMPHOCYTE ADHESION MOLECULES$198,318
R43 · FY2001 · AI
Development of an HPV-E6 Cervical Neoplasia Test for Use in Centralized Diagnosti$198,247
R43 · FY2012 · CA
A Novel Drug To Reduce Neronal Damage Following Stroke$197,624
R43 · FY2005 · NS
A Novel Diagnostic for Oncogenic HPV$189,568
R43 · FY2003 · CA
Development of an HPV-E6 Cervical Neoplasia Test for Use in Centralized Diagnosti$94,891
R43 · FY2013 · CA